Sort   by:  
 Page size 
UnknownMechanochemical Activation of NaHCO<sub>3</sub>: A Solid CO<sub>2</sub> Surrogate in Carboxylation Reactions.
Not available
S-EPMC12270364 | biostudies-literature
UnknownSafety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis.
Not available
S-EPMC3365876 | biostudies-literature
UnknownAcquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms.
Not available
S-EPMC3663431 | biostudies-literature
TranscriptomicsTranscription profiling of human CD43+ cells from idiopathic myelofibrosis patients vs normal individuals identifies a set of disease-associated genes and reveals the clinical significance of Wilms tumor gene 1 (WT1)
IM CD34+ vs BM CD34+ cells Experiment Overall Design: Differential gene expression profiling of CD34+ cells purified from the PB of 15 IM patients (3 distinct pools) and from the BM of 15 healthy subjects (3 distinct pools)
ORGANISM(S): Homo sapiens 
2007-11-08 | E-GEOD-3410 | biostudies-arrayexpress
TranscriptomicsGene expression profile of mutated and wild-type PMF CD34+ cells
Primary mielofibrosis (PMF) is a rare chronic myeloproliferative disorder characterized by the accumulation of abnormal megakaryocytes (Mks) in the bone marrow (BM), variable degrees of BM fibrosis, osteosclerosis and angiogenesis, immature myeloid and erythroid cells, and tear-drop erythrocytes in ...
ORGANISM(S): Homo sapiens 
2013-07-23 | E-GEOD-41812 | biostudies-arrayexpress
UnknownComparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivity.
Not available
S-EPMC7371578 | biostudies-literature
UnknownInfrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative 'idiopathic' erythrocytosis.
Not available
S-EPMC3762108 | biostudies-literature
UnknownSafety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.
Not available
S-EPMC7387307 | biostudies-literature
UnknownTargeted deep sequencing in polycythemia vera and essential thrombocythemia.
Not available
S-EPMC5744051 | biostudies-literature
UnknownImpact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study.
Not available
S-EPMC4441358 | biostudies-literature
Sort   by:  
 Page size